FDA attacking chelation therapy for autism

Sunday, October 17, 2010 by: Ethan A. Huff, staff writer
Tags: chelation, autism, health news

(NaturalNews) The U.S. Food and Drug Administration (FDA) recently sent warning letters to a handful of companies selling chelation therapy products that help to treat serious conditions like autism, Parkinson's, and Alzheimer's disease. Chelation agents remove toxic heavy metals from the body, which ultimately improves blood flow and restores good health. But according to the FDA, such substances are "unapproved drugs and devices" that cannot legally be sold for such purposes.

Even though thousands of people have used, and continue to use, chelation therapy to safely and successfully improve or reverse serious conditions, the FDA has decided that the products may be dangerous, despite a total lack of evidence to back this belief.

"We don't have evidence of a lot of adverse events, but [that] does not mean there are not health problems associated with them," Charles Lee from the FDA's division of new drugs and labeling compliance at the center for drug evaluation and research is quoted as saying in a recent Washington Post article. But that does not necessarily mean there are health problems associated with them, either.

Chelation therapies are commonly prescribed by many doctors to eliminate toxic substances like mercury, lead and aluminum from their patients' bodies. These harmful agents can build up in brain and muscle tissue, leading to various disorders and illnesses that conventional medicine has a difficult time understanding and explaining.

According to a 2007 survey conducted by the U.S. Centers for Disease Control and Prevention (CDC) of alternative medicine use, roughly 111,000 people over the age of 18 used some kind of chelation therapy between 2006 and 2007.

To learn more about the benefits of chelation therapy, check out this informative piece written by Dr. Julian Whitaker:
https://www.naturalnews.com/027338_chelation_...

Sources for this story include:

http://www.washingtonpost.com/wp-dyn/content...